Overview of the clinical current needs and potential applications for long-acting and implantable delivery systems

[1]  H. McCarthy,et al.  Design, Formulation, and Evaluation of Novel Dissolving Microarray Patches Containing Rilpivirine for Intravaginal Delivery , 2019, Advanced healthcare materials.

[2]  L. Phillips,et al.  The pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient adults. , 2002, The Journal of clinical endocrinology and metabolism.

[3]  Marian E. Gindy,et al.  Extended-Duration MK-8591-Eluting Implant as a Candidate for HIV Treatment and Prevention , 2018, Antimicrobial Agents and Chemotherapy.

[4]  Ryan F. Donnelly,et al.  Successful application of large microneedle patches by human volunteers , 2017, International journal of pharmaceutics.

[5]  Manfred Westphal,et al.  A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. , 2003, Neuro-oncology.

[6]  Bhavana Kokane,et al.  Sublingual route for systemic drug delivery , 2018, Journal of Drug Delivery and Therapeutics.

[7]  Byung Kook Lee,et al.  Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formation. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Rebecca S. Shawgo,et al.  Biocompatibility and biofouling of MEMS drug delivery devices. , 2003, Biomaterials.

[9]  Vrinda Gote,et al.  Ocular Drug Delivery: Present Innovations and Future Challenges , 2019, The Journal of Pharmacology and Experimental Therapeutics.

[10]  S. Geary,et al.  Evolution of drug-eluting biomedical implants for sustained drug delivery. , 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[11]  Eneko Larrañeta,et al.  Transdermal delivery of vitamin K using dissolving microneedles for the prevention of vitamin K deficiency bleeding , 2018, International journal of pharmaceutics.

[12]  Ryan F. Donnelly,et al.  A facile system to evaluate in vitro drug release from dissolving microneedle arrays , 2016, International journal of pharmaceutics.

[13]  Eneko Larrañeta,et al.  Slowly dissolving intradermal microneedles , 2019, Nature Biomedical Engineering.

[14]  Sarah A. Stewart,et al.  Poly(caprolactone)-Based Coatings on 3D-Printed Biodegradable Implants: A Novel Strategy to Prolong Delivery of Hydrophilic Drugs , 2020, Molecular pharmaceutics.

[15]  R. Verma,et al.  Inhalation drug delivery devices: technology update , 2015, Medical devices.

[16]  D. Wise,et al.  Chemotherapy of tuberculosis in mice using single implants of isoniazid and pyrazinamide. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[17]  D. Breimer,et al.  Rectal Drug Administration , 1982, Clinical pharmacokinetics.

[18]  S. Grossman,et al.  Analgesic applications for a subcutaneous implant that continuously releases hydromorphone , 2011 .

[19]  M. Minhas,et al.  Evaluation of microneedles-assisted in situ depot forming poloxamer gels for sustained transdermal drug delivery , 2019, Drug Delivery and Translational Research.

[20]  P. Schlegel.  A review of the pharmacokinetic and pharmacological properties of a once‐yearly administered histrelin acetate implant in the treatment of prostate cancer , 2009, BJU international.

[21]  N. Schooler.  Relapse and rehospitalization: comparing oral and depot antipsychotics. , 2003, The Journal of clinical psychiatry.

[22]  I. M. Shaikh,et al.  Nasal Drug Delivery System-Factors Affecting and Applications , 2007 .

[23]  Eneko Larrañeta,et al.  Microarray patches: potentially useful delivery systems for long-acting nanosuspensions. , 2017, Drug discovery today.

[24]  R. Persad,et al.  Patient self‐injection: a new approach to administering luteinizing hormone‐releasing hormone analogues , 2000, BJU international.

[25]  Chun Gwon Park,et al.  Implantable multireservoir device with stimulus-responsive membrane for on-demand and pulsatile delivery of growth hormone , 2019, Proceedings of the National Academy of Sciences.

[26]  Maelíosa T. C. McCrudden,et al.  Solid lipid nanoparticle-based dissolving microneedles: A promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Eneko Larrañeta,et al.  3D Printing of Drug-Loaded Thermoplastic Polyurethane Meshes: A Potential Material for Soft Tissue Reinforcement in Vaginal Surgery , 2020, Pharmaceutics.

[28]  David J. Mooney,et al.  Designing hydrogels for controlled drug delivery. , 2016, Nature reviews. Materials.

[29]  R. Kern,et al.  In-office Placement of Mometasone Furoate Sinus Implants for Recurrent Nasal Polyps: A Pooled Analysis , 2019, American journal of rhinology & allergy.

[30]  Sarah A. Stewart,et al.  Implantable Polymeric Drug Delivery Devices: Classification, Manufacture, Materials, and Clinical Applications , 2018, Polymers.

[31]  Pilar Ventosa-Andrés,et al.  DRUG SOLUBILITY : IMPORTANCE AND ENHANCEMENT TECHNIQUES , 2016 .

[32]  Ryan F. Donnelly,et al.  Microneedle arrays as transdermal and intradermal drug delivery systems: Materials science, manufacture and commercial development , 2016 .

[33]  Jan Scott,et al.  Patient Related Outcome Measures Dovepress Nonadherence with Antipsychotic Medication in Schizophrenia: Challenges and Management Strategies , 2022 .

[34]  Maelíosa T. C. McCrudden,et al.  Evaluation of the clinical impact of repeat application of hydrogel-forming microneedle array patches , 2020, Drug Delivery and Translational Research.

[35]  Ryan F. Donnelly,et al.  Design, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspension , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Eneko Larrañeta,et al.  Fused Deposition Modeling as an Effective Tool for Anti-Infective Dialysis Catheter Fabrication. , 2019, ACS biomaterials science & engineering.

[37]  Jun-Pil Jee,et al.  Long acting injectable formulations: the state of the arts and challenges of poly(lactic-co-glycolic acid) microsphere, hydrogel, organogel and liquid crystal , 2019, Journal of Pharmaceutical Investigation.

[38]  Thomas J. Smith,et al.  An intravaginal ring for the simultaneous delivery of multiple drugs. , 2012, Journal of pharmaceutical sciences.

[39]  M. Soheilian,et al.  Sustained Release Intraocular Drug Delivery Devices for Treatment of Uveitis , 2011, Journal of ophthalmic & vision research.

[40]  Ankit Parikh,et al.  Drug-Eluting Nasal Implants: Formulation, Characterization, Clinical Applications and Challenges , 2014, Pharmaceutics.

[41]  R. Dammerman,et al.  Pharmacokinetics and Safety of Risperidone Subcutaneous Implants in Stable Patients With Schizophrenia , 2018, Clinical pharmacology in drug development.

[42]  A. Zornoza,et al.  In Vitro release from reverse poloxamine/α-cyclodextrin matrices: modelling and comparison of dissolution profiles. , 2014, Journal of pharmaceutical sciences.

[43]  S. Deweerdt.  Tracing the US opioid crisis to its roots , 2019, Nature.

[44]  D. Podzamczer,et al.  Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial , 2017, The Lancet.

[45]  I. Antal,et al.  Drug excipients. , 2006, Current medicinal chemistry.

[46]  M. Guarnieri,et al.  New developments in managing opioid addiction: impact of a subdermal buprenorphine implant , 2017, Drug design, development and therapy.

[47]  Susan Hua,et al.  Physiological and Pharmaceutical Considerations for Rectal Drug Formulations , 2019, Front. Pharmacol..

[48]  P. Bishop.  Clinical Experiment in Oestrin Therapy , 1938, British medical journal.

[49]  Mark R. Prausnitz,et al.  Rapidly separable microneedle patch for the sustained release of a contraceptive , 2019, Nature Biomedical Engineering.

[50]  D. Friend.  Advances in vaginal drug delivery , 2011, Drug Delivery and Translational Research.

[51]  S. Teoh,et al.  Sustained-release ganciclovir implant as prophylaxis for cytomegalovirus retinitis in a child undergoing bone marrow transplantation , 2013, Eye.

[52]  Dusan Losic,et al.  Drug-releasing implants: current progress, challenges and perspectives. , 2014, Journal of materials chemistry. B.

[53]  Ryan F. Donnelly,et al.  Design and characterisation of a dissolving microneedle patch for intradermal vaccination with heat-inactivated bacteria: A proof of concept study , 2018, International journal of pharmaceutics.

[54]  Il-Joo Cho,et al.  MEMS devices for drug delivery☆ , 2017, Advanced drug delivery reviews.

[55]  B. Goldspiel,et al.  Goserelin Acetate Implant: A Depot Luteinizing Hormone-Releasing Hormone Analog for Advanced Prostate Cancer , 1991, DICP : the annals of pharmacotherapy.

[56]  G. Sassolas,et al.  Comparison of octreotide acetate LAR and lanreotide SR in patients with acromegaly , 2000, Clinical endocrinology.

[57]  Sarah A. Stewart,et al.  Fused deposition modelling for the development of drug loaded cardiovascular prosthesis. , 2021, International journal of pharmaceutics.

[58]  P. Heng,et al.  Buccal Delivery Systems , 2003, Drug development and industrial pharmacy.

[59]  W. Weyers,et al.  Phase 1 clinical study with Bioneedles, a delivery platform for biopharmaceuticals. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[60]  S. Newman.  Drug delivery to the lungs: challenges and opportunities. , 2017, Therapeutic delivery.

[61]  D. Wise,et al.  Sustained release of isoniazid in vivo from a single implant of a biodegradable polymer. , 1991, Tubercle.

[62]  M. De Hert,et al.  Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review , 2013, Therapeutic advances in psychopharmacology.

[63]  P. Zahedi,et al.  Polymeric drug delivery systems for localized cancer chemotherapy , 2010, Drug delivery.

[64]  Ryan F. Donnelly,et al.  Microneedles: A New Frontier in Nanomedicine Delivery , 2016, Pharmaceutical Research.

[65]  Eneko Larrañeta,et al.  Development of a Biodegradable Subcutaneous Implant for Prolonged Drug Delivery Using 3D Printing , 2020, Pharmaceutics.

[66]  I. Brosens,et al.  Long-Acting Hormonal Contraception , 2015, Women's health.

[67]  Samir Mitragotri,et al.  An overview of clinical and commercial impact of drug delivery systems. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[68]  D. Lamprou,et al.  3D printed estradiol-eluting urogynecological mesh Implants: Influence of material and mesh geometry on their mechanical properties. , 2020, International journal of pharmaceutics.

[69]  M. Aron,et al.  Effect of GemRIS (gemcitabine-releasing intravesical system, TAR-200) on antitumor activity in muscle-invasive bladder cancer (MIBC). , 2017 .

[70]  N. Birbilis,et al.  Metallic implant drug/device combinations for controlled drug release in orthopaedic applications. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[71]  F. D. Guerra,et al.  Stimuli-Responsive Drug Release from Smart Polymers , 2019, Journal of functional biomaterials.

[72]  Mayur M. Patel,et al.  Long-Acting Injectables: Current Perspectives and Future Promise. , 2019, Critical reviews in therapeutic drug carrier systems.

[73]  Eneko Larrañeta,et al.  Non-covalent hydrogels of cyclodextrins and poloxamines for the controlled release of proteins. , 2014, Carbohydrate polymers.

[74]  Bankole A Johnson,et al.  Naltrexone long-acting formulation in the treatment of alcohol dependence , 2007, Therapeutics and clinical risk management.

[75]  Kevin S. Li,et al.  Current Strategies for Drug Delivery to the Inner Ear , 2013 .

[76]  E. Seyedjafari,et al.  Pharmaceutical implants: classification, limitations and therapeutic applications , 2020, Pharmaceutical development and technology.

[77]  Anda Vintiloiu,et al.  Organogels and their use in drug delivery--a review. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[78]  L. Cardozo,et al.  The vagina as a route for drug delivery: a review , 2013, International Urogynecology Journal.

[79]  Ryan F. Donnelly,et al.  Hydrogel-Forming Microneedle Arrays Can Be Effectively Inserted in Skin by Self-Application: A Pilot Study Centred on Pharmacist Intervention and a Patient Information Leaflet , 2014, Pharmaceutical Research.

[80]  Eneko Larrañeta,et al.  Recent advances in combination of microneedles and nanomedicines for lymphatic targeted drug delivery. , 2021, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[81]  D. Pavan-Langston,et al.  Pilocarpine ocusert system for sustained control of ocular hypertension. , 1975, Archives of ophthalmology.

[82]  M. R. Ravi Kumar,et al.  Polymeric Controlled Drug-Delivery Systems: Perspective Issues and Opportunities , 2001, Drug development and industrial pharmacy.

[83]  Feng Zhang,et al.  Otic drug delivery systems: formulation principles and recent developments , 2018, Drug development and industrial pharmacy.

[84]  Paula T Hammond,et al.  Composite Dissolving Microneedles for Coordinated Control of Antigen and Adjuvant Delivery Kinetics in Transcutaneous Vaccination , 2012, Advanced functional materials.

[85]  K. Fowers,et al.  OncoGel (ReGel/paclitaxel)--clinical applications for a novel paclitaxel delivery system. , 2009, Advanced drug delivery reviews.

[86]  M. Cima,et al.  Continuous Intravesical Lidocaine Treatment for Interstitial Cystitis/Bladder Pain Syndrome: Safety and Efficacy of a New Drug Delivery Device , 2012, Science Translational Medicine.

[87]  J. Prihartono,et al.  Five-year experience with Norplant. , 1987, Contraception.

[88]  Eneko Larrañeta,et al.  Hydrogels based on poly(methyl vinyl ether-co-maleic acid) and Tween 85 for sustained delivery of hydrophobic drugs. , 2018, International journal of pharmaceutics.